GRAIL, Inc. (GRAL)
58.59
-2.31
(-3.79%)
USD |
NASDAQ |
Jun 10, 16:00
59.54
+0.95
(+1.62%)
Pre-Market: 08:22
GRAIL Price : 58.59 for June 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 60.19 | 63.71 | 58.42 | 58.59 | 794697.0 |
| Jun 09, 2026 | 63.05 | 63.05 | 57.79 | 60.90 | 556544.0 |
| Jun 08, 2026 | 60.60 | 61.99 | 58.56 | 61.52 | 659436.0 |
| Jun 05, 2026 | 63.99 | 65.53 | 59.66 | 59.98 | 760458.0 |
| Jun 04, 2026 | 61.08 | 68.93 | 61.08 | 66.55 | 1.276M |
| Jun 03, 2026 | 59.90 | 61.34 | 56.70 | 61.13 | 799196.0 |
| Jun 02, 2026 | 64.00 | 64.32 | 58.50 | 59.90 | 1.587M |
| Jun 01, 2026 | 58.83 | 65.23 | 54.52 | 64.40 | 2.613M |
| May 29, 2026 | 73.90 | 74.49 | 70.74 | 71.68 | 1.248M |
| May 28, 2026 | 71.70 | 79.50 | 71.44 | 73.92 | 1.080M |
| May 27, 2026 | 69.44 | 71.65 | 68.43 | 71.42 | 661221.0 |
| May 26, 2026 | 67.34 | 72.06 | 67.34 | 68.96 | 935643.0 |
| May 22, 2026 | 68.32 | 69.62 | 66.89 | 67.19 | 410940.0 |
| May 21, 2026 | 64.28 | 68.39 | 63.03 | 67.86 | 502595.0 |
| May 20, 2026 | 62.24 | 66.44 | 61.88 | 66.03 | 748894.0 |
| May 19, 2026 | 59.81 | 62.10 | 58.26 | 60.99 | 553149.0 |
| May 18, 2026 | 60.60 | 63.98 | 59.39 | 60.71 | 421223.0 |
| May 15, 2026 | 60.00 | 61.76 | 58.37 | 59.65 | 642472.0 |
| May 14, 2026 | 60.47 | 63.51 | 60.10 | 61.80 | 666935.0 |
| May 13, 2026 | 60.50 | 62.30 | 59.50 | 60.47 | 502740.0 |
| May 12, 2026 | 60.02 | 62.76 | 59.11 | 61.98 | 416360.0 |
| May 11, 2026 | 61.42 | 62.59 | 60.17 | 61.26 | 588909.0 |
| May 08, 2026 | 62.89 | 63.00 | 60.58 | 61.64 | 537754.0 |
| May 07, 2026 | 63.50 | 64.68 | 61.04 | 62.92 | 643195.0 |
| May 06, 2026 | 56.00 | 63.74 | 53.01 | 62.75 | 1.257M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Apogee Therapeutics, Inc. | 82.72 |
| Evommune, Inc. | 20.49 |
| Arrowhead Pharmaceuticals, Inc. | 70.73 |
| Oncolytics Biotech, Inc. | 0.8001 |
| Sangamo Therapeutics, Inc. | 0.149 |
Price Related Metrics
| PS Ratio | 14.38 |
| Price to Book Value | 0.9638 |
| Earnings Yield | -17.71% |
| Market Cap | 2.410B |